These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

836 related items for PubMed ID: 16144666

  • 1. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE, Veys JA, Eskridge MR, Woodruff RD, Hall MC.
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C, Song C, Hong JH, Kim CS, Ahn H.
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [Abstract] [Full Text] [Related]

  • 3. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H, Borgmann V, Nagel R, Al-Abadi H.
    Cancer; 2001 Nov 01; 92(9):2280-5. PubMed ID: 11745282
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B, Patard JJ, Méjean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes JL, de la Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valéri A, Meyer N, Jacqmin D, Lang H.
    Eur Urol; 2009 Feb 01; 55(2):452-9. PubMed ID: 18692951
    [Abstract] [Full Text] [Related]

  • 5. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
    Ishimura T, Sakai I, Hara I, Eto H, Miyake H.
    Int J Urol; 2004 May 01; 11(5):264-8. PubMed ID: 15147540
    [Abstract] [Full Text] [Related]

  • 6. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
    Amin MB, Paner GP, Alvarado-Cabrero I, Young AN, Stricker HJ, Lyles RH, Moch H.
    Am J Surg Pathol; 2008 Dec 01; 32(12):1822-34. PubMed ID: 18813125
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, Bui MH, Liu X, Horvath S, Figlin RA, Belldegrun AS.
    Cancer; 2005 Jun 15; 103(12):2517-25. PubMed ID: 15880379
    [Abstract] [Full Text] [Related]

  • 8. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF, Ribeiro-Filho LA, Antunes AA, Crippa A, Nesrallah L, Gonçalves PD, Leite KR, Srougi M.
    J Urol; 2007 Aug 15; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [Abstract] [Full Text] [Related]

  • 9. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
    Lee SE, Byun SS, Oh JK, Lee SC, Chang IH, Choe G, Hong SK.
    J Urol; 2006 Oct 15; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
    [Abstract] [Full Text] [Related]

  • 10. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
    Brookman-Amissah S, Kendel F, Spivak I, Pflanz S, Roigas J, Klotz T, May M.
    BJU Int; 2009 May 15; 103(10):1375-80. PubMed ID: 19040527
    [Abstract] [Full Text] [Related]

  • 11. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC, Zincke H, Lohse CM, Sebo TJ, Riehle D, Weaver AL, Blute ML.
    Cancer; 2002 Apr 15; 94(8):2180-4. PubMed ID: 12001115
    [Abstract] [Full Text] [Related]

  • 12. [Pathological prognostic indicators in renal cell carcinoma].
    Rey Rey J, León Ramírez D, López García S, Fernández Vázquez P, Benavente Delgado J, Ojea Calvo A.
    Actas Urol Esp; 2010 Jan 15; 34(1):71-7. PubMed ID: 20223135
    [Abstract] [Full Text] [Related]

  • 13. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V, Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project, Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.
    BJU Int; 2012 Jul 15; 110(1):76-83. PubMed ID: 22044519
    [Abstract] [Full Text] [Related]

  • 14. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
    Ficarra V, Martignoni G, Maffei N, Brunelli M, Novara G, Zanolla L, Pea M, Artibani W.
    Cancer; 2005 Jan 01; 103(1):68-75. PubMed ID: 15573369
    [Abstract] [Full Text] [Related]

  • 15. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC, Han KR, Bui MH, Pantuck AJ, Dorey FJ, Figlin RA, Belldegrun A.
    Cancer; 2003 Dec 15; 98(12):2566-75. PubMed ID: 14669275
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
    Kramer BA, Gao X, Davis M, Hall M, Holzbeierlein J, Tawfik O.
    J Am Coll Surg; 2005 Oct 15; 201(4):565-70. PubMed ID: 16183495
    [Abstract] [Full Text] [Related]

  • 17. Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.
    Kawaciuk I, Hyrsl L, Dusek P, Jarolim L, Schmidt M, Kaliska V, Chocholaty M, Vesely S.
    Scand J Urol Nephrol; 2008 Oct 15; 42(5):406-11. PubMed ID: 18932106
    [Abstract] [Full Text] [Related]

  • 18. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P.
    Scand J Urol Nephrol Suppl; 1994 Oct 15; 165():1-48. PubMed ID: 7871395
    [Abstract] [Full Text] [Related]

  • 19. The Cleveland Clinic experience with papillary (chromophil) renal cell carcinoma: clinical outcome with histopathological correlation.
    Chow GK, Myles J, Novick AC.
    Can J Urol; 2001 Apr 15; 8(2):1223-8. PubMed ID: 11375785
    [Abstract] [Full Text] [Related]

  • 20. External validation of an international multicenter study to predict survival in Korean patients with pT2N0M0 renal cell carcinoma.
    Ku JH, Moon KC, Kwak C, Kim HH.
    Urology; 2009 Aug 15; 74(2):359-63. PubMed ID: 19501879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.